Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs4,656334-   
Low Rs3,788241-   
Sales per share (Unadj.) Rs1,481.499.4-  
Earnings per share (Unadj.) Rs270.7-25.1-  
Cash flow per share (Unadj.) Rs345.7-20.8-  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.678.0-  
Shares outstanding (eoy) m166.53168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.82.9 98.5%   
Avg P/E ratio x15.6-11.5 -135.8%  
P/CF ratio (eoy) x12.2-13.9 -88.1%  
Price / Book Value ratio x3.03.7 82.4%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,03948,552 1,448.0%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m46,4663,047 1,524.9%   
Avg. sales/employee Rs Th03,908.8-  
Avg. wages/employee Rs Th0709.8-  
Avg. net profit/employee Rs Th0-984.9-  
INCOME DATA
Net Sales Rs m246,69716,780 1,470.1%  
Other income Rs m10,555118 8,982.3%   
Total revenues Rs m257,25216,898 1,522.4%   
Gross profit Rs m63,860-2,908 -2,196.1%  
Depreciation Rs m12,502724 1,726.2%   
Interest Rs m1,428455 314.2%   
Profit before tax Rs m60,485-3,969 -1,523.9%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,412248 6,214.1%   
Profit after tax Rs m45,073-4,228 -1,066.0%  
Gross profit margin %25.9-17.3 -149.4%  
Effective tax rate %25.5-6.2 -407.8%   
Net profit margin %18.3-25.2 -72.5%  
BALANCE SHEET DATA
Current assets Rs m203,16112,290 1,653.0%   
Current liabilities Rs m85,7216,915 1,239.6%   
Net working cap to sales %47.632.0 148.6%  
Current ratio x2.41.8 133.3%  
Inventory Days Days79111 71.4%  
Debtors Days Days107124 86.5%  
Net fixed assets Rs m112,6387,164 1,572.3%   
Share capital Rs m83378 1,069.2%   
"Free" reserves Rs m230,5710-   
Net worth Rs m231,40413,171 1,757.0%   
Long term debt Rs m1,2784,628 27.6%   
Total assets Rs m315,79924,881 1,269.3%  
Interest coverage x43.4-7.7 -560.7%   
Debt to equity ratio x00.4 1.6%  
Sales to assets ratio x0.80.7 115.8%   
Return on assets %14.7-15.2 -97.1%  
Return on equity %19.5-32.1 -60.7%  
Return on capital %26.6-19.8 -134.3%  
Exports to sales %52.20-   
Imports to sales %16.80-   
Net fx Rs m87,3190-   
CASH FLOW
From Operations Rs m58,8751,432 4,110.4%  
From Investments Rs m-41,373-440 9,407.4%  
From Financial Activity Rs m-26,8614,201 -639.5%  
Net Cashflow Rs m-9,0735,193 -174.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.61 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: BLISS GVS PHARMA  ZENITH DRUGS LTD.  SANJIVANI PA  AMRUTANJAN HEALTHCARE  DIVIS LABORATORIES  



Today's Market

Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8% Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8%(10:30 am)

Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.